+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immunoprecipitation Market 2024-2028

  • PDF Icon

    Report

  • 161 Pages
  • March 2024
  • Region: Global
  • TechNavio
  • ID: 5949782
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The immunoprecipitation market is forecasted to grow by USD 270.1 mn during 2023-2028, accelerating at a CAGR of 6.01% during the forecast period. The report on the immunoprecipitation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing r and d in biopharmaceuticals, rising demand for therapeutic antibodies, and growing focus on newborn screening tests.

The immunoprecipitation market is segmented as below:

By End-user

  • Academic and research institutes
  • Contract research organizations
  • Pharmaceutical and biotechnology companies

By Type

  • Chromatin immunoprecipitation
  • Individual protein immunoprecipitation
  • Co-immunoprecipitation
  • RNA immunoprecipitation

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the rising number of genome projects as one of the prime reasons driving the immunoprecipitation market growth during the next few years. Also, increasing clinical trials and growing expansion of contract manufacturing organizations and cros will lead to sizable demand in the market.

The report on the immunoprecipitation market covers the following areas:

  • Immunoprecipitation market sizing
  • Immunoprecipitation market forecast
  • Immunoprecipitation market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunoprecipitation market vendors that include Active Motif Inc., Agilent Technologies Inc., Becton Dickinson and Company, Bio Rad Laboratories Inc., Cell Signaling Technology Inc., Chargen Life Sciences LLP, CLOUD CLONE CORP., Creative Biolabs, Danaher Corp., GenScript Biotech Corp., JSR Micro Inc., Merck KGaA, OriGene Technologies Inc., PerkinElmer Inc, Proteintech Group Inc., Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Sino Biological Inc., and Thermo Fisher Scientific Inc.. Also, the immunoprecipitation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global immunoprecipitation market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global immunoprecipitation market 2018 - 2022 ($ million)
4.2 End-User Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - End-User Segment 2018 - 2022 ($ million)
4.3 Type Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user
6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Academic and research institutes - Market size and forecast 2023-2028
Exhibit 34: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
6.4 Contract research organizations - Market size and forecast 2023-2028
Exhibit 38: Chart on Contract research organizations - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Contract research organizations - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Contract research organizations - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Contract research organizations - Year-over-year growth 2023-2028 (%)
6.5 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
Exhibit 42: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by End-user
Exhibit 46: Market opportunity by End-user ($ million)
Exhibit 47: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Type
7.1 Market segments
Exhibit 48: Chart on Type - Market share 2023-2028 (%)
Exhibit 49: Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Exhibit 50: Chart on Comparison by Type
Exhibit 51: Data Table on Comparison by Type
7.3 Chromatin immunoprecipitation - Market size and forecast 2023-2028
Exhibit 52: Chart on Chromatin immunoprecipitation - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Chromatin immunoprecipitation - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Chromatin immunoprecipitation - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Chromatin immunoprecipitation - Year-over-year growth 2023-2028 (%)
7.4 Individual protein immunoprecipitation - Market size and forecast 2023-2028
Exhibit 56: Chart on Individual protein immunoprecipitation - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Individual protein immunoprecipitation - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Individual protein immunoprecipitation - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Individual protein immunoprecipitation - Year-over-year growth 2023-2028 (%)
7.5 Co-immunoprecipitation - Market size and forecast 2023-2028
Exhibit 60: Chart on Co-immunoprecipitation - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Co-immunoprecipitation - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Co-immunoprecipitation - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Co-immunoprecipitation - Year-over-year growth 2023-2028 (%)
7.6 RNA immunoprecipitation - Market size and forecast 2023-2028
Exhibit 64: Chart on RNA immunoprecipitation - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Data Table on RNA immunoprecipitation - Market size and forecast 2023-2028 ($ million)
Exhibit 66: Chart on RNA immunoprecipitation - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on RNA immunoprecipitation - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by Type
Exhibit 68: Market opportunity by Type ($ million)
Exhibit 69: Data Table on Market opportunity by Type ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 Germany - Market size and forecast 2023-2028
Exhibit 103: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Exhibit 107: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 108: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 109: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ million)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 Active Motif Inc.
Exhibit 119: Active Motif Inc. - Overview
Exhibit 120: Active Motif Inc. - Product/Service
Exhibit 121: Active Motif Inc. - Key offerings
12.4 Agilent Technologies Inc.
Exhibit 122: Agilent Technologies Inc. - Overview
Exhibit 123: Agilent Technologies Inc. - Business segments
Exhibit 124: Agilent Technologies Inc. - Key news
Exhibit 125: Agilent Technologies Inc. - Key offerings
Exhibit 126: Agilent Technologies Inc. - Segment focus
12.5 Becton Dickinson and Company
Exhibit 127: Becton Dickinson and Company - Overview
Exhibit 128: Becton Dickinson and Company - Business segments
Exhibit 129: Becton Dickinson and Company - Key news
Exhibit 130: Becton Dickinson and Company - Key offerings
Exhibit 131: Becton Dickinson and Company - Segment focus
12.6 Bio Rad Laboratories Inc.
Exhibit 132: Bio Rad Laboratories Inc. - Overview
Exhibit 133: Bio Rad Laboratories Inc. - Business segments
Exhibit 134: Bio Rad Laboratories Inc. - Key news
Exhibit 135: Bio Rad Laboratories Inc. - Key offerings
Exhibit 136: Bio Rad Laboratories Inc. - Segment focus
12.7 Cell Signaling Technology Inc.
Exhibit 137: Cell Signaling Technology Inc. - Overview
Exhibit 138: Cell Signaling Technology Inc. - Product/Service
Exhibit 139: Cell Signaling Technology Inc. - Key offerings
12.8 Danaher Corp.
Exhibit 140: Danaher Corp. - Overview
Exhibit 141: Danaher Corp. - Business segments
Exhibit 142: Danaher Corp. - Key news
Exhibit 143: Danaher Corp. - Key offerings
Exhibit 144: Danaher Corp. - Segment focus
12.9 GenScript Biotech Corp.
Exhibit 145: GenScript Biotech Corp. - Overview
Exhibit 146: GenScript Biotech Corp. - Business segments
Exhibit 147: GenScript Biotech Corp. - Key news
Exhibit 148: GenScript Biotech Corp. - Key offerings
Exhibit 149: GenScript Biotech Corp. - Segment focus
12.10 JSR Micro Inc.
Exhibit 150: JSR Micro Inc. - Overview
Exhibit 151: JSR Micro Inc. - Product/Service
Exhibit 152: JSR Micro Inc. - Key offerings
12.11 Merck KGaA
Exhibit 153: Merck KGaA - Overview
Exhibit 154: Merck KGaA - Business segments
Exhibit 155: Merck KGaA - Key news
Exhibit 156: Merck KGaA - Key offerings
Exhibit 157: Merck KGaA - Segment focus
12.12 OriGene Technologies Inc.
Exhibit 158: OriGene Technologies Inc. - Overview
Exhibit 159: OriGene Technologies Inc. - Product/Service
Exhibit 160: OriGene Technologies Inc. - Key offerings
12.13 PerkinElmer Inc
Exhibit 161: PerkinElmer Inc - Overview
Exhibit 162: PerkinElmer Inc - Business segments
Exhibit 163: PerkinElmer Inc - Key news
Exhibit 164: PerkinElmer Inc - Key offerings
Exhibit 165: PerkinElmer Inc - Segment focus
12.14 Proteintech Group Inc.
Exhibit 166: Proteintech Group Inc. - Overview
Exhibit 167: Proteintech Group Inc. - Product/Service
Exhibit 168: Proteintech Group Inc. - Key offerings
12.15 Rockland Immunochemicals Inc.
Exhibit 169: Rockland Immunochemicals Inc. - Overview
Exhibit 170: Rockland Immunochemicals Inc. - Product/Service
Exhibit 171: Rockland Immunochemicals Inc. - Key offerings
12.16 Santa Cruz Biotechnology Inc.
Exhibit 172: Santa Cruz Biotechnology Inc. - Overview
Exhibit 173: Santa Cruz Biotechnology Inc. - Product/Service
Exhibit 174: Santa Cruz Biotechnology Inc. - Key offerings
12.17 Thermo Fisher Scientific Inc.
Exhibit 175: Thermo Fisher Scientific Inc. - Overview
Exhibit 176: Thermo Fisher Scientific Inc. - Business segments
Exhibit 177: Thermo Fisher Scientific Inc. - Key news
Exhibit 178: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 179: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 180: Inclusions checklist
Exhibit 181: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 182: Currency conversion rates for US$
13.4 Research methodology
Exhibit 183: Research methodology
Exhibit 184: Validation techniques employed for market sizing
Exhibit 185: Information sources
13.5 List of abbreviations
Exhibit 186: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global immunoprecipitation market 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - End-User Segment 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on End-user - Market share 2023-2028 (%)
Exhibits 31: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by End-user
Exhibits 33: Data Table on Comparison by End-user
Exhibits 34: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Contract research organizations - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Contract research organizations - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Contract research organizations - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Contract research organizations - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibits 43: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibits 44: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibits 46: Market opportunity by End-user ($ million)
Exhibits 47: Data Table on Market opportunity by End-user ($ million)
Exhibits 48: Chart on Type - Market share 2023-2028 (%)
Exhibits 49: Data Table on Type - Market share 2023-2028 (%)
Exhibits 50: Chart on Comparison by Type
Exhibits 51: Data Table on Comparison by Type
Exhibits 52: Chart on Chromatin immunoprecipitation - Market size and forecast 2023-2028 ($ million)
Exhibits 53: Data Table on Chromatin immunoprecipitation - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Chart on Chromatin immunoprecipitation - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Chromatin immunoprecipitation - Year-over-year growth 2023-2028 (%)
Exhibits 56: Chart on Individual protein immunoprecipitation - Market size and forecast 2023-2028 ($ million)
Exhibits 57: Data Table on Individual protein immunoprecipitation - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Chart on Individual protein immunoprecipitation - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Individual protein immunoprecipitation - Year-over-year growth 2023-2028 (%)
Exhibits 60: Chart on Co-immunoprecipitation - Market size and forecast 2023-2028 ($ million)
Exhibits 61: Data Table on Co-immunoprecipitation - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Chart on Co-immunoprecipitation - Year-over-year growth 2023-2028 (%)
Exhibits 63: Data Table on Co-immunoprecipitation - Year-over-year growth 2023-2028 (%)
Exhibits 64: Chart on RNA immunoprecipitation - Market size and forecast 2023-2028 ($ million)
Exhibits 65: Data Table on RNA immunoprecipitation - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Chart on RNA immunoprecipitation - Year-over-year growth 2023-2028 (%)
Exhibits 67: Data Table on RNA immunoprecipitation - Year-over-year growth 2023-2028 (%)
Exhibits 68: Market opportunity by Type ($ million)
Exhibits 69: Data Table on Market opportunity by Type ($ million)
Exhibits 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 73: Chart on Geographic comparison
Exhibits 74: Data Table on Geographic comparison
Exhibits 75: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 92: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 100: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 103: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 104: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 105: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 107: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 108: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 109: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 110: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 111: Market opportunity By Geographical Landscape ($ million)
Exhibits 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 113: Impact of drivers and challenges in 2023 and 2028
Exhibits 114: Overview on Criticality of inputs and Factors of differentiation
Exhibits 115: Overview on factors of disruption
Exhibits 116: Impact of key risks on business
Exhibits 117: Vendors covered
Exhibits 118: Matrix on vendor position and classification
Exhibits 119: Active Motif Inc. - Overview
Exhibits 120: Active Motif Inc. - Product/Service
Exhibits 121: Active Motif Inc. - Key offerings
Exhibits 122: Agilent Technologies Inc. - Overview
Exhibits 123: Agilent Technologies Inc. - Business segments
Exhibits 124: Agilent Technologies Inc. - Key news
Exhibits 125: Agilent Technologies Inc. - Key offerings
Exhibits 126: Agilent Technologies Inc. - Segment focus
Exhibits 127: Becton Dickinson and Company - Overview
Exhibits 128: Becton Dickinson and Company - Business segments
Exhibits 129: Becton Dickinson and Company - Key news
Exhibits 130: Becton Dickinson and Company - Key offerings
Exhibits 131: Becton Dickinson and Company - Segment focus
Exhibits 132: Bio Rad Laboratories Inc. - Overview
Exhibits 133: Bio Rad Laboratories Inc. - Business segments
Exhibits 134: Bio Rad Laboratories Inc. - Key news
Exhibits 135: Bio Rad Laboratories Inc. - Key offerings
Exhibits 136: Bio Rad Laboratories Inc. - Segment focus
Exhibits 137: Cell Signaling Technology Inc. - Overview
Exhibits 138: Cell Signaling Technology Inc. - Product/Service
Exhibits 139: Cell Signaling Technology Inc. - Key offerings
Exhibits 140: Danaher Corp. - Overview
Exhibits 141: Danaher Corp. - Business segments
Exhibits 142: Danaher Corp. - Key news
Exhibits 143: Danaher Corp. - Key offerings
Exhibits 144: Danaher Corp. - Segment focus
Exhibits 145: GenScript Biotech Corp. - Overview
Exhibits 146: GenScript Biotech Corp. - Business segments
Exhibits 147: GenScript Biotech Corp. - Key news
Exhibits 148: GenScript Biotech Corp. - Key offerings
Exhibits 149: GenScript Biotech Corp. - Segment focus
Exhibits 150: JSR Micro Inc. - Overview
Exhibits 151: JSR Micro Inc. - Product/Service
Exhibits 152: JSR Micro Inc. - Key offerings
Exhibits 153: Merck KGaA - Overview
Exhibits 154: Merck KGaA - Business segments
Exhibits 155: Merck KGaA - Key news
Exhibits 156: Merck KGaA - Key offerings
Exhibits 157: Merck KGaA - Segment focus
Exhibits 158: OriGene Technologies Inc. - Overview
Exhibits 159: OriGene Technologies Inc. - Product/Service
Exhibits 160: OriGene Technologies Inc. - Key offerings
Exhibits 161: PerkinElmer Inc - Overview
Exhibits 162: PerkinElmer Inc - Business segments
Exhibits 163: PerkinElmer Inc - Key news
Exhibits 164: PerkinElmer Inc - Key offerings
Exhibits 165: PerkinElmer Inc - Segment focus
Exhibits 166: Proteintech Group Inc. - Overview
Exhibits 167: Proteintech Group Inc. - Product/Service
Exhibits 168: Proteintech Group Inc. - Key offerings
Exhibits 169: Rockland Immunochemicals Inc. - Overview
Exhibits 170: Rockland Immunochemicals Inc. - Product/Service
Exhibits 171: Rockland Immunochemicals Inc. - Key offerings
Exhibits 172: Santa Cruz Biotechnology Inc. - Overview
Exhibits 173: Santa Cruz Biotechnology Inc. - Product/Service
Exhibits 174: Santa Cruz Biotechnology Inc. - Key offerings
Exhibits 175: Thermo Fisher Scientific Inc. - Overview
Exhibits 176: Thermo Fisher Scientific Inc. - Business segments
Exhibits 177: Thermo Fisher Scientific Inc. - Key news
Exhibits 178: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 179: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 180: Inclusions checklist
Exhibits 181: Exclusions checklist
Exhibits 182: Currency conversion rates for US$
Exhibits 183: Research methodology
Exhibits 184: Validation techniques employed for market sizing
Exhibits 185: Information sources
Exhibits 186: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global immunoprecipitation market: Active Motif Inc., Agilent Technologies Inc., Becton Dickinson and Company, Bio Rad Laboratories Inc., Cell Signaling Technology Inc., Chargen Life Sciences LLP, CLOUD CLONE CORP., Creative Biolabs, Danaher Corp., GenScript Biotech Corp., JSR Micro Inc., Merck KGaA, OriGene Technologies Inc., PerkinElmer Inc, Proteintech Group Inc., Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Sino Biological Inc., and Thermo Fisher Scientific Inc..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is rising number of genome projects.'

According to the report, one of the major drivers for this market is the increasing r and d in biopharmaceuticals.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Active Motif Inc.
  • Agilent Technologies Inc.
  • Becton Dickinson and Company
  • Bio Rad Laboratories Inc.
  • Cell Signaling Technology Inc.
  • Chargen Life Sciences LLP
  • CLOUD CLONE CORP.
  • Creative Biolabs
  • Danaher Corp.
  • GenScript Biotech Corp.
  • JSR Micro Inc.
  • Merck KGaA
  • OriGene Technologies Inc.
  • PerkinElmer Inc
  • Proteintech Group Inc.
  • Rockland Immunochemicals Inc.
  • Santa Cruz Biotechnology Inc.
  • Sino Biological Inc.
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Immunoprecipitation Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Immunoprecipitation Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 115 Pages
  • Global
From
Immunoprecipitation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Immunoprecipitation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 182 Pages
  • Global
From
Immunoprecipitation Market Analysis & Forecast to 2024-2034 - Product Image

Immunoprecipitation Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Chromatin immunoprecipitation (ChIP) Sequencing Global Market Report 2024 - Product Image

Chromatin immunoprecipitation (ChIP) Sequencing Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Immunoprecipitation Market Size, Share and Trends Analysis Report by Product (Kits, Reagents), Type, End-use (Academic & Research Institutes, Pharma & Biotech Companies, CROs), and Region 2024-2030 - Product Image

Immunoprecipitation Market Size, Share and Trends Analysis Report by Product (Kits, Reagents), Type, End-use (Academic & Research Institutes, Pharma & Biotech Companies, CROs), and Region 2024-2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.